Hongru Yang

862 total citations
29 papers, 556 citations indexed

About

Hongru Yang is a scholar working on Molecular Biology, Molecular Medicine and Oncology. According to data from OpenAlex, Hongru Yang has authored 29 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Molecular Medicine and 7 papers in Oncology. Recurrent topics in Hongru Yang's work include Curcumin's Biomedical Applications (9 papers), Nanoparticle-Based Drug Delivery (5 papers) and COVID-19 Clinical Research Studies (4 papers). Hongru Yang is often cited by papers focused on Curcumin's Biomedical Applications (9 papers), Nanoparticle-Based Drug Delivery (5 papers) and COVID-19 Clinical Research Studies (4 papers). Hongru Yang collaborates with scholars based in China and United States. Hongru Yang's co-authors include Yumeng Wei, Chao Pi, Ling Zhao, Xiaoli Zheng, Hao Liu, Ting Feng, Qin Zhou, Shousong Cao, Jing Liang and Chenyu Sun and has published in prestigious journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics and Molecules.

In The Last Decade

Hongru Yang

29 papers receiving 548 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hongru Yang 195 115 90 86 61 29 556
Sahil Kumar 235 1.2× 43 0.4× 31 0.3× 131 1.5× 92 1.5× 46 760
Feng Shao 353 1.8× 41 0.4× 41 0.5× 144 1.7× 102 1.7× 51 756
Mehboob Hoque 249 1.3× 36 0.3× 38 0.4× 74 0.9× 52 0.9× 42 633
Wensheng Zheng 288 1.5× 51 0.4× 64 0.7× 126 1.5× 50 0.8× 35 752
Ge Hong 222 1.1× 44 0.4× 63 0.7× 107 1.2× 35 0.6× 35 659
Chengwu Shen 179 0.9× 51 0.4× 44 0.5× 46 0.5× 70 1.1× 28 421
Feifan Xie 83 0.4× 25 0.2× 81 0.9× 74 0.9× 42 0.7× 23 462
Sharron Stewart 187 1.0× 26 0.2× 38 0.4× 33 0.4× 39 0.6× 30 559
Swarna Bale 220 1.1× 23 0.2× 49 0.5× 40 0.5× 74 1.2× 28 807
Somsubhra Thakur Choudhury 145 0.7× 104 0.9× 33 0.4× 73 0.8× 45 0.7× 12 486

Countries citing papers authored by Hongru Yang

Since Specialization
Citations

This map shows the geographic impact of Hongru Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongru Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongru Yang more than expected).

Fields of papers citing papers by Hongru Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongru Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongru Yang. The network helps show where Hongru Yang may publish in the future.

Co-authorship network of co-authors of Hongru Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongru Yang. A scholar is included among the top collaborators of Hongru Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongru Yang. Hongru Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Jie, Li Zhao, Li Zhao, et al.. (2024). Preparation and anti-colon cancer effect of a novel curcumin analogue (CA8): in vivo and in vitro evaluation. Frontiers in Pharmacology. 15. 1464626–1464626. 3 indexed citations
2.
Wei, Yumeng, Zheng Li, Jie Wen, et al.. (2024). Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo. International Journal of Nanomedicine. Volume 19. 13411–13428. 2 indexed citations
3.
Wei, Yumeng, Jingwen Ma, Jie Wen, et al.. (2023). Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo. International Journal of Nanomedicine. Volume 18. 2087–2107. 15 indexed citations
4.
Hu, Hui, Chao Liu, Yumei Zhao, et al.. (2022). Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma. Scientific Reports. 12(1). 10401–10401. 10 indexed citations
5.
6.
Sun, Chenyu, Yue Chen, Yile Wu, et al.. (2021). Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis. Digestive Diseases and Sciences. 66(11). 3929–3937. 17 indexed citations
7.
Ma, Shaodi, Tiantian Han, Chenyu Sun, et al.. (2021). Does aspirin reduce the incidence, recurrence, and mortality of colorectal cancer? A meta-analysis of randomized clinical trials. International Journal of Colorectal Disease. 36(8). 1653–1666. 16 indexed citations
8.
Yang, Hongru, et al.. (2021). Corylin sensitizes breast cancer cells to overcome tamoxifen resistance by regulating OAS1/miR-22-3p/SIRT1 axis. Acta Biochimica Polonica. 68(4). 757–764. 9 indexed citations
9.
Han, Tiantian, Shaodi Ma, Chenyu Sun, et al.. (2021). Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis. Archives of Medical Research. 53(2). 186–195. 42 indexed citations
10.
Chen, Yue, Chenyu Sun, Yile Wu, et al.. (2021). Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis. Journal of Cancer Research and Clinical Oncology. 147(9). 2681–2691. 20 indexed citations
11.
Pi, Chao, Shaozhi Fu, Hongru Yang, et al.. (2020). Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer. Expert Opinion on Drug Delivery. 17(10). 1473–1484. 37 indexed citations
12.
Xu, Ting, Chao Pi, Hongru Yang, et al.. (2020). Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB. Journal of Cancer. 11(13). 3955–3964. 28 indexed citations
13.
Zhang, Xiaomei, Chao Pi, Hongru Yang, et al.. (2020). <p>Review of Curcumin Physicochemical Targeting Delivery System</p>. International Journal of Nanomedicine. Volume 15. 9799–9821. 50 indexed citations
14.
Zhang, Yingjie, Zhouxue Wu, Haowen Pang, et al.. (2018). Preliminary report of a single‐channel applicator in high dose rate afterloading brachytherapy for cervical cancer. Cancer Science. 109(12). 3953–3961. 3 indexed citations
15.
Wu, Peng, et al.. (2018). Prognostic value of TIGAR and LC3B protein expression in nasopharyngeal carcinoma. Cancer Management and Research. Volume 10. 5605–5616. 6 indexed citations
16.
Yang, Hongru, Yumeng Wei, Shousong Cao, et al.. (2017). Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- κB Signaling Pathways. Journal of Cancer. 8(18). 3697–3706. 74 indexed citations
17.
Wei, Yumeng, Jing Liang, Xiaoli Zheng, et al.. (2016). Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer. International Journal of Nanomedicine. Volume 12. 251–261. 56 indexed citations
18.
Deng, Xi, Jingbo Wu, Jianwen Zhang, et al.. (2016). MicroRNA-183 promotes migration and invasion of CD133+/CD326+ lung adenocarcinoma initiating cells via PTPN4 inhibition. Tumor Biology. 37(8). 11289–11297. 18 indexed citations
19.
Wei, Yumeng, et al.. (2016). A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice. Drug Design Development and Therapy. 10. 997–997. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sahil Kumar Breakdown of academic impact, for papers by Feng Shao Breakdown of academic impact, for papers by Mehboob Hoque Breakdown of academic impact, for papers by Wensheng Zheng Breakdown of academic impact, for papers by Ge Hong Breakdown of academic impact, for papers by Chengwu Shen Breakdown of academic impact, for papers by Feifan Xie Breakdown of academic impact, for papers by Sharron Stewart Breakdown of academic impact, for papers by Swarna Bale Breakdown of academic impact, for papers by Somsubhra Thakur Choudhury
Rankless by CCL
2026